Tweet
Well if you look at how Aderans went about it I think you can expect Replicel to say something like yes our treatment has shown some efficacy and we intend to pursue this further with phase 2 trials. Don't be expecting too much. Doubt you'll get any great pics either. I think it's probably going to be a non event and they will just get on with phase 2.
-
-
Not sure how truthful it is, but from an NBT pump piece:
Bottom-line: we expect a big move for the stock valuation post-Phase II/a results….and NBT Communications has a significant amount of media coverage lined up for the post-reveal media tour.
A post-reveal media tour sounds a bit bigger than "we have had some promising results and plan to move on accordingly to future clinical trials."Comment
-
Unless the trials are a complete and utter failure (which is rather unlikely, since the stated primary goal of the current trial is merely to establish the safety of the treatment), I suspect they'll go through with the publicity.
The point is that no matter what the results, they're almost certainly going to couch their statements in generic terms about how the treatment has potential or looks promising. There's no way that, as a result of such a limited trial, they're going to start offering specifics such as stating that their treatment can restore 60% of original hair density or turn a NW6 into a NW2 or the like.Comment
-
Wow Replicel stock took a dump today.
Comment
-
Seriously i don't get why you would care. I see 10 or so people crying whenever replicel stocks drop but no one bothers to say anything when it goes back up. if it's insider trading or a huge dumping i assure you the asking price would drop more than 10%Comment
-
Yes, but I made a rather small purchase a couple of weeks ago and pushed the stock back over $2.00/share. That was the first time ever that my personal purchase caused a stock to change price. A couple of buyers today could have caused the opposite result to happen.
I would judge the activity today to be minor as only 11,365 shares traded. Yes, there was selling pressure today, but it was insignificant. I would venture to guess that it was probably someone gettting cold feet prior to the news release or who knows what.
Bottom line, expect increasing volatility in the upcoming weeks. Watch the volume and price for possible indications of insider selling or buying.Comment
-
We should all buy stock and drive the price up, thereby enhancing the likelihood of positive clinical trial results.Comment
-
we're getting closer. I'm so nervous, I've been following Replicel for a long time. It has given me hope and strength to deal with this shit, I don't know what I'll do if they don't have the fix.Comment
-
Don't get too excited, people. I too believe it's going to be a non-event event. We've been let down before by others. We'll probably hear the usual "in the next 5 years...".Comment
-
As I've said already, I really don't see them revealing that much. I remember people started flipping out back when Histogen were saying 60% and Aderans were saying 55% or whatever the numbers were.
I really want it to work but some people here set themselves up for disappointment thinking announcement day is going to be like the 4th of July with fireworks to celebrate the great news.
When I see some real macro photography with an improvement I'll get excited. I'm sick of numbers. Non-event because it's so early in the process. I do imagine they'll move on to phase 2 so 3 years from now we'll have the new wave of posters eagerly awaiting phase 2 results like kids before Christmas.
That being said it will be a little disappointing if they have nothing but I can definitely see them getting to phase 2.Comment
Comment